Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'STIBOGLUCONATE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 202 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sundar, S
      Drug resistance in Indian visceral leishmaniasis

      TROPICAL MEDICINE & INTERNATIONAL HEALTH
    2. Croft, SL
      Monitoring drug resistance in leishmaniasis

      TROPICAL MEDICINE & INTERNATIONAL HEALTH
    3. Bryceson, A
      A policy for leishmaniasis with respect to the prevention and control of drug resistance

      TROPICAL MEDICINE & INTERNATIONAL HEALTH
    4. Thakur, CP; Ahmed, S
      Observations on amphotericin B treatment of kala-azar given in a rural setup in Bihar, India

      INDIAN JOURNAL OF MEDICAL RESEARCH
    5. Teixiera, MJ; de Almeida, YM; Viana, JR; Holanda, JG; Rodrigues, TP; Prata, JRC; Coelho, IVB; Rao, VS; Pompeu, MML
      In vitro and in vivo leishmanicidal activity of 2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone (lapachol)

      PHYTOTHERAPY RESEARCH
    6. Thakur, CP
      A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    7. Kuyucu, N; Kara, C; Bakirtac, A; Tezic, T
      Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    8. Haidar, NA; Diab, ABL; El-Sheikh, AM
      Visceral leishmaniasis in children in the Yemen

      SAUDI MEDICAL JOURNAL
    9. Palmer, RA; Tran, D; Hepburn, NC; Ashton, RE
      The management of cutaneous leishmaniasis from Belize

      CLINICAL AND EXPERIMENTAL DERMATOLOGY
    10. Bryceson, A
      Current issues in the treatment of visceral leishmaniasis

      MEDICAL MICROBIOLOGY AND IMMUNOLOGY
    11. Sundar, S
      Treatment of visceral leishmaniasis

      MEDICAL MICROBIOLOGY AND IMMUNOLOGY
    12. Arana, B; Rizzo, N; Diaz, A
      Chemotherapy of cutaneous leishmaniasis: a review

      MEDICAL MICROBIOLOGY AND IMMUNOLOGY
    13. Sereno, D; Holzmuller, P; Mangot, I; Cuny, G; Ouaissi, A; Lemesre, JL
      Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    14. Sereno, D; Roy, G; Lemesre, JL; Papadopoulou, B; Ouellette, M
      DNA transformation of Leishmania infantum axenic amastigotes and their usein drug screening

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    15. Thakur, CP; Dedet, JP; Narain, S; Pratlong, F
      Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India

      TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    16. Zijlstra, EE; El-Hassan, AM
      Leishmaniasis in Sudan 3. Visceral leishmaniasis

      TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    17. Zijlstra, EE; El-Hassan, AM
      Leishmaniasis in Sudan 4. Post kala-azar dermal leishmaniasis

      TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    18. Afrin, F; Dey, T; Anam, K; Ali, N
      Leishmanicidal activity of stearylamine-bearing liposomes in vitro

      JOURNAL OF PARASITOLOGY
    19. Shaked-Mishan, P; Ulrich, N; Ephros, M; Zilberstein, D
      Novel intracellular Sb-V reducing activity correlates with antimony susceptibility in Leishmania donovani

      JOURNAL OF BIOLOGICAL CHEMISTRY
    20. Romero, GAS; Guerra, MVD; Paes, MG; Macedo, VD
      Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) Guyanensis in Brazil: Therapeutic response to meglumine antimoniate

      AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    21. Arana, BA; Mendoza, CE; Rizzo, NR; Kroeger, A
      Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointmentin Guatemala

      AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    22. Sundar, S; Pai, K; Kumar, R; Pathak-Tripathi, K; Gam, AA; Ray, M; Kenney, RT
      Resistance to treatment in Kala-azar: Speciation of isolates from northeast India

      AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    23. Palacios, R; Osorio, LE; Grajales, LF; Ochoa, MT
      Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species

      AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    24. Berhe, N; Hailu, A; Abraham, Y; Tadesse, Y; Breivik, K; Abebe, Y
      Inter-current and nosocomial infections among visceral leishmaniasis patients in Ethiopia: an observational study

      ACTA TROPICA
    25. Veeken, H; Pecoul, B
      Drugs for 'neglected diseases': a bitter pill

      TROPICAL MEDICINE & INTERNATIONAL HEALTH
    26. Veeken, H; Ritmeijer, K; Seaman, J; Davidson, R
      A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan

      TROPICAL MEDICINE & INTERNATIONAL HEALTH
    27. Sundar, S; More, DK; Singh, MK; Singh, VP; Sharma, S; Makharia, A; Kumar, PCK; Murray, HW
      Failure of pentavalent antimony in visceral leishmaniasis in India: Reportfrom the center of the Indian epidemic

      CLINICAL INFECTIOUS DISEASES
    28. Sundar, S; Makharia, A; More, DK; Agrawal, G; Voss, A; Fischer, C; Bachmann, P; Murray, HW
      Short-course of oral miltefosine for treatment of visceral leishmaniasis

      CLINICAL INFECTIOUS DISEASES
    29. Goihman-Yahr, M
      Antihelminthic and antiparasitic drugs: Unapproved used or indications

      CLINICS IN DERMATOLOGY
    30. Hepburn, NC
      Cutaneous leishmaniasis

      CLINICAL AND EXPERIMENTAL DERMATOLOGY
    31. Brecelj, M; Pikelj, F; Gubensek, F; Anderluh, G
      Polymerase chain reaction as a diagnostic tool for detecting Leishmania

      INFECTION
    32. Hantson, P; Luyasu, S; Haufroid, V; Lambert, M
      Antimony excretion in a patient with renal impairment during meglumine antimoniate therapy

      PHARMACOTHERAPY
    33. Frezard, F; Michalick, MSM; Soares, CF; Demicheli, C
      Novel methods for the encapsulation of meglumine antimoniate into liposomes

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    34. Donald, PR; Sirgel, FA; Kanyok, TP; Danziger, LH; Venter, A; Botha, FJ; Parkin, DP; Seifart, HI; Van de Wal, BW; Martiz, JS; Mitchison, DA
      Early bactericidal activity of paromomycin (aminosidine) in patients with smear-positive pulmonary tuberculosis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    35. Llorente, S; Gimeno, L; Navarro, MJ; Moreno, S; Rodriguez-Girones, M
      Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials

      TRANSPLANTATION
    36. Boelaert, M; Criel, B; Leeuwenburg, J; Van Damme, W; Le Ray, D; Van der Stuyft, P
      Visceral leishmaniasis control: a public health perspective

      TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    37. Thakur, CP; Kanyok, TP; Pandey, AK; Sinha, GP; Zaniewski, AE; Houlihan, HH; Olliaro, P
      A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis

      TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    38. Thakur, CP; Kanyok, TP; Pandey, AK; Sinha, GP; Messick, C; Olliaro, P
      Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study

      TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    39. Sundar, S; Gupta, LB; Rastogi, V; Agrawal, G; Murray, HW
      Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis

      TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    40. Murray, HW; Delph-Etienne, S
      Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis

      INFECTION AND IMMUNITY
    41. Alexander, J; Carter, KC; Al-Fasi, N; Satoskar, A; Brombacher, F
      Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis

      EUROPEAN JOURNAL OF IMMUNOLOGY
    42. Grech, V; Mizzi, J; Mangion, M; Vella, C
      Visceral leishmaniasis in Malta - an 18 year paediatric, population based study

      ARCHIVES OF DISEASE IN CHILDHOOD
    43. Dabiri, S; Meymandi, SS; Hayes, MM; Soleimani, F; Kharazmi, A
      Intralesional autotherapy of cutaneous leishmaniasis with buffy coat cells: cytological findings

      ACTA TROPICA
    44. Seaton, RA; Morrison, J; Man, I; Watson, J; Nathwani, D
      Out-patient parenteral antimicrobial therapy - a viable option for the management of cutaneous leishmaniasis

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    45. Belloli, C; Crescenzo, G; Carli, S; Zaghini, A; Mengozzi, G; Bertini, S; Ormas, P
      Disposition of antimony and aminosidine combination after multiple subcutaneous injections in dogs

      VETERINARY JOURNAL
    46. Meyerhoff, A
      US Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis

      CLINICAL INFECTIOUS DISEASES
    47. Bora, D
      Epidemiology of visceral leishmaniasis in India

      NATIONAL MEDICAL JOURNAL OF INDIA
    48. Loiseau, PM; Bories, C
      Recent strategies for the chemotherapy of visceral leishmaniasis

      CURRENT OPINION IN INFECTIOUS DISEASES
    49. Foulquie, MR; Louassini, M; Castanys, S; Gamarro, F; Benitz, R; Adroher, FJ
      Different catalytic activities of hexokinase and phosphofructokinase in wild type and Glucantime-resistant Leishmania promastigotes appears not causatively related to resistance

      EUROPEAN JOURNAL OF PROTISTOLOGY
    50. Minodier, P; Faraut-Gambarelli, E; Piarroux, R; Gire, C; Garnier, JM; Dumon, H
      Visceral leishmaniasis treatment in children.

      ARCHIVES DE PEDIATRIE
    51. Gangneux, JP
      Treatment of visceral leishmaniasis: recent developments

      PRESSE MEDICALE
    52. Moskowitz, PF; Kurban, AK
      Treatment of cutaneous leishmaniasis: Retrospectives and advances for the 21st century

      CLINICS IN DERMATOLOGY
    53. Kenner, JR; Aronson, NE; Benson, PM
      The United States military and leishmaniasis

      DERMATOLOGIC CLINICS
    54. Segura, I; Garcia-Bolao, I
      Meglumine antimoniate, amiodarone and torsades de pointes: a case report

      RESUSCITATION
    55. Laguna, F; Lopez-Velez, R; Pulido, F; Salas, A; Torre-Cisneros, J; Torres, E; Medrano, FJ; Sanz, J; Pico, G; Gomez-Rodrigo, J; Pasquau, J; Alvar, J
      Treatment of visceral leishmaniasis in HIV-infected patients: a randomizedtrial comparing meglumine antimoniate with amphotericin B

      AIDS
    56. Davidson, RN
      Visceral leishmaniasis in clinical practice

      JOURNAL OF INFECTION
    57. Ribeiro, ALP; Drummond, JB; Volpini, AC; Andrade, AC; Passos, VMA
      Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    58. Ephros, M; Bitnun, A; Shaked, P; Waldman, E; Zilberstein, D
      Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    59. Al-Abdely, HM; Graybill, JR; Loebenberg, D; Melby, PC
      Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    60. Gangneux, JP; Dullin, M; Sulahian, A; Garin, YJF; Derouin, F
      Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    61. Boelaert, M; Lynen, L; Desjeux, P; Van der Stuyft, P
      Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis

      BULLETIN OF THE WORLD HEALTH ORGANIZATION
    62. Snawder, JE; Tirmenstein, MA; Mathias, PI; Toraason, M
      Induction of stress proteins in rat cardiac myocytes by antimony

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    63. Thakur, CP; Singh, RK; Hassan, SM; Kumar, R; Narain, S; Kumar, A
      Amphotericin B deoxycholate treatment of visceral leishmaniasis with newermodes of administration and precautions: a study of 938 cases

      TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    64. Smego, RA; Castiglia, M; Asperilla, MO
      Lymphocutaneous syndrome - A review of non-sporothrix causes

      MEDICINE
    65. Grogl, M; Schuster, BG; Ellis, WY; Berman, JD
      Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (aminosidine) and gentamicin

      JOURNAL OF PARASITOLOGY
    66. Robledo, SM; Valencia, AZ; Saravia, NG
      Sensitivity to Glucantime (R) of Leishmania viannia isolated from patientsprior to treatment

      JOURNAL OF PARASITOLOGY
    67. Lira, R; Sundar, S; Makharia, A; Kenney, R; Gam, A; Saraiva, E; Sacks, D
      Evidence that the high incidence of treatment failures in Indian kala-azaris due to the emergence of antimony-resistant strains of Leishmania donovani

      JOURNAL OF INFECTIOUS DISEASES
    68. Mujtaba, G; Khalid, M
      Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis

      INTERNATIONAL JOURNAL OF DERMATOLOGY
    69. Berman, J; Dietze, R
      Treatment of visceral leishmaniasis with Amphotericin B Colloidal Dispersion

      CHEMOTHERAPY
    70. Everlien, H; Hockertz, S
      Combined liposomal immuno- and chemotherapy of visceral leishmaniasis

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    71. Vargas-Gonzalez, A; Canto-Lara, SB; Damian-Centeno, AG; Andrade-Narvaez, FJ
      Response of cutaneous leishmaniasis (Chiclero's ulcer) to treatment with meglumine antimoniate in southeast Mexico

      AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    72. Delgado, J; Macias, J; Pineda, JA; Corzo, JE; Gonzalez-Moreno, MP; De la Rosa, R; Sanchez-Quijano, A; Leal, M; Lissen, E
      High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients

      AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    73. Dassopoulos, T; Ehrenpreis, ED
      Acute pancreatitis in human immunodeficiency virus-infected patients: A review

      AMERICAN JOURNAL OF MEDICINE
    74. Burbach, G; May, J; Harms, G; Bienzle, U
      Leishmaniasis

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    75. LOCKWOOD DNJ
      SOME GOOD-NEWS FOR TREATMENT OF VISCERAL LEISHMANIASIS IN BIHAR - COMMENTARY

      BMJ. British medical journal
    76. MOREIRA ESA; ANACLETO C; PETRILLOPEIXOTO MD
      EFFECT OF GLUCANTIME ON FIELD AND PATIENT ISOLATES OF NEW-WORLD LEISHMANIA - USE OF GROWTH-PARAMETERS OF PROMASTIGOTES TO ASSESS ANTIMONY SUSCEPTIBILITY

      Parasitology research
    77. UCHEGBU IF; VYAS SP
      NONIONIC SURFACTANT BASED VESICLES (NIOSOMES) IN DRUG-DELIVERY

      International journal of pharmaceutics
    78. BALANAFOUCE R; REGUERA RM; CUBRIA JC; ORDONEZ D
      THE PHARMACOLOGY OF LEISHMANIASIS

      General pharmacology
    79. VALLADARES JE; RIERA C; ALBEROLA J; GALLEGO M; PORTUS M; CRISTOFOL C; FRANQUELO C; ARBOIX M
      PHARMACOKINETICS OF MEGLUMINE ANTIMONIATE AFTER ADMINISTRATION OF A MULTIPLE-DOSE IN DOGS EXPERIMENTALLY INFECTED WITH LEISHMANIA-INFANTUM

      Veterinary parasitology
    80. Alkhawajah, A
      Recent trends in the treatment of cutaneous leishmaniasis

      ANNALS OF SAUDI MEDICINE
    81. REYMOND JM; DESMEULES J
      SODIUM STIBOGLUCONATE (PENTOSTAN) OVERDOSE IN A PATIENT WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME

      Therapeutic drug monitoring
    82. LUCUMI A; ROBLEDO S; GAMA V; SARAVIA NG
      SENSITIVITY OF LEISHMANIA-VIANNIA-PANAMENSIS TO PENTAVALENT ANTIMONY IS CORRELATED WITH THE FORMATION OF CLEAVABLE DNA-PROTEIN COMPLEXES

      Antimicrobial agents and chemotherapy
    83. LEFICHOUX Y; ROUSSEAU D; FERRUA B; RUETTE S; LELIEVRE A; GROUSSON D; KUBAR J
      SHORT-TERM AND LONG-TERM EFFICACY OF HEXADECYLPHOSPHOCHOLINE AGAINST ESTABLISHED LEISHMANIA-INFANTUM INFECTION IN BALB C MICE/

      Antimicrobial agents and chemotherapy
    84. Sereno, D; Cavaleyra, M; Zemzoumi, K; Maquaire, S; Ouaissi, A; Lemesre, JL
      Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    85. BERMAN JD; BADARO R; THAKUR CP; WASUNNA KM; BEHBEHANI K; DAVIDSON R; KUZOE F; PANG L; WEERASURIYA K; BRYCESON ADM
      EFFICACY AND SAFETY OF LIPOSOMAL AMPHOTERICIN-B (AMBISOME) FOR VISCERAL LEISHMANIASIS IN ENDEMIC DEVELOPING-COUNTRIES

      Bulletin of the World Health Organization
    86. BERENGUER J; GOMEZCAMPDERA F; PADILLA B; RODRIGUEZFERRERO H; ANAYA F; MORENO S; VALDERRABANO F
      VISCERAL LEISHMANIASIS (KALA-AZAR) IN TRANSPLANT RECIPIENTS - CASE-REPORT AND REVIEW

      Transplantation
    87. OSMAN OF; OSKAM L; ZIJLSTRA EE; ELHASSAN AM; ELNAEIM DA; KAGER PA
      USE OF THE POLYMERASE-CHAIN-REACTION TO ASSESS THE SUCCESS OF VISCERAL LEISHMANIASIS TREATMENT

      Transactions of the Royal Society of Tropical Medicine and Hygiene
    88. Martin, S; Gambel, J; Jackson, J; Aronson, N; Gupta, R; Rowton, E; Perich, M; McEvoy, P; Berman, J; Magill, A; Hoke, C
      Leishmaniasis in the United States Military

      MILITARY MEDICINE
    89. VAZQUEZ ST; SALAZAR MAG; MARTIN MJJ; MARTINEZ JL
      TORSADE-DE-POINTES SECONDARY TO TREATMENT WITH PENTAVALENT ANTIMONIALDRUGS

      Medicina Clinica
    90. MITTAL N; GUPTA N; SAKSENA S; GOYAL N; ROY U; RASTOGI AK
      PROTECTIVE EFFECT OF PICROLIV FROM PICRORHIZA-KURROA AGAINST LEISHMANIA-DONOVANI INFECTIONS IN MESOCRICETUS-AURATUS

      Life sciences (1973)
    91. Williams, D; Mullen, AB; Baillie, AJ; Carter, KC
      Comparison of the efficacy of free and non-ionic-surfactant vesicular formulations of paromomycin in a murine model of visceral leishmaniasis

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    92. Davidson, RN
      Practical guide for the treatment of leishmaniasis

      DRUGS
    93. SMITH HR; CONNOR MP; BEER TW; ASHTON RE
      THE USE OF POLYMERASE-CHAIN-REACTION IN NEW-WORLD CUTANEOUS LEISHMANIASIS

      British journal of dermatology
    94. ASTE N; PAU M; FERRELI C; BIGGIO P
      INTRALESIONAL TREATMENT OF CUTANEOUS LEISHMANIASIS WITH MEGLUMINE ANTIMONIATE

      British journal of dermatology
    95. BEUGIN S; EDWARDS K; KARLSSON G; OLLIVON M; LESIEUR S
      NEW STERICALLY STABILIZED VESICLES BASED ON NONIONIC SURFACTANT, CHOLESTEROL, AND POLY(ETHYLENE GLYCOL)-CHOLESTEROL CONJUGATES

      Biophysical journal
    96. SUNDAR S; GOYAL AK; MORE DK; SINGH MK; MURRAY HW
      TREATMENT OF ANTIMONY-UNRESPONSIVE INDIAN VISCERAL LEISHMANIASIS WITHULTRA-SHORT COURSES OF AMPHOTERICIN-B-LIPID COMPLEX

      Annals of tropical medicine and parasitology
    97. OLIVA G; GRADONI L; CORTESE L; ORSINI S; CIARAMELLA P; SCALONE A; DELUNA R; PERSECHINO A
      COMPARATIVE EFFICACY OF MEGLUMINE ANTIMONIATE AND AMINOSIDINE SULFATE, ALONE OR IN COMBINATION, IN CANINE LEISHMANIASIS

      Annals of tropical medicine and parasitology
    98. SUNDAR S; SINHA PR; AGRAWAL NK; SRIVASTAVA R; RAINEY PM; BERMAN JD; MURRAY HW; SINGH VP
      A CLUSTER OF CASES OF SEVERE CARDIOTOXICITY AMONG KALA-AZAR PATIENTS TREATED WITH A HIGH-OSMOLARITY LOT OF SODIUM ANTIMONY GLUCONATE

      The American journal of tropical medicine and hygiene
    99. VEXENAT JA; OLLIARO PL; DECASTRO JAF; CAVALCANTE R; CAMPOS JHF; TAVARES JP; MILES MA
      CLINICAL RECOVERY AND LIMITED CURE IN CANINE VISCERAL LEISHMANIASIS TREATED WITH AMINOSIDINE (PAROMOMYCIN)

      The American journal of tropical medicine and hygiene
    100. Hendrickx, EP; Agudelo, SD; Munoz, DL; Puerta, JA; Bernal, IDV
      Lack of efficacy of mefloquine in the treatment of new world cutaneous leishmaniasis in Colombia

      AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/01/21 alle ore 06:26:16